Assessment of real-world treatment patterns and outcomes of olutasidenib in patients with mutated isocitrate dehydrogenase 1 Acute Myeloid Leukemia previously treated with venetoclax using electronic health record dataCatherine Lai, Aaron Sheppard, Yasmin Abaza et al.|Blood|2025Cited by 0